✨ Health and Trade Notices
NEW ZEALAND GAZETTE, No. 11 — 2 FEBRUARY 2017
ii. authorise in writing general practitioners receiving clients from Hawke’s Bay District Health Board Opioid Substitution Treatment Service as specified under subsection (2)(d); and
c. authorise in writing general practitioners receiving clients from Hawke’s Bay District Health Board Opioid Substitution Treatment Service as specified under subsection (2)(d).
Conditions
-
Controlled drugs may only be prescribed, administered or supplied to people who are or have been clients of Hawke’s Bay District Health Board Opioid Substitution Treatment Service.
-
This approval expires on 31 December 2017.
Dated at Wellington this 7th day of October 2016.
DR JOHN CRAWSHAW, Director of Mental Health.
Notice of Application to Register a Trade Name Product (Notice No. MPI 719)
Maree Zinzley, Manager Approvals Operations of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: Miravis
Reference: P9442
Active Ingredient and Concentration:
Pydiflumetofen 200g/L
Formulation Type: Suspension concentrate
General Use Claim:
For the control of a powdery mildew in grapes and early blight in potato.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
a. must state in full the reasons for making the submission;
b. may state any decision sought on that application; and
c. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
a. where submissions on this application are to be sent;
b. where requests for copies of the public information relating to the application can be sent;
c. where public information relating to the application can be viewed; and
d. the director-general’s address for service:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Syngenta Crop Protection Limited, Tower 2, Level 7, 110 Symonds Street, Auckland 1010. Postal Address: Private Bag 92618, Symonds Street, Auckland 1010.
Dated at Wellington this 31st day of January 2017.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated
Next Page →
✨ LLM interpretation of page content
🏥
Approval of Hawke’s Bay District Health Board Opioid Substitution Treatment Service and Clinician
(continued from previous page)
🏥 Health & Social Welfare7 October 2016
Misuse of Drugs Act, Opioid Substitution Treatment, Approval, Hawke’s Bay District Health Board, Clinician
- DR JOHN CRAWSHAW, Director of Mental Health
🌾 Notice of Application to Register a Trade Name Product
🌾 Primary Industries & Resources31 January 2017
Trade Name Product, Agricultural Compounds, Veterinary Medicines, Registration, Miravis, Pydiflumetofen
- Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries
NZ Gazette 2017, No 11